肺脾同治治疗甲状腺结节100例临床观察

目的：观察肺脾同治治疗甲状腺结节的疗效。方法：将依据诊断标准诊断为甲状腺结节100例患者随机分为两组，进行临床观察。观察组50例，给予自拟养肺阴、健脾气、化痰散结中药治疗；对照组50例，给予口服左旋甲状腺素治疗；疗程3个月。结果：治疗前后两组经统计学处理，痊愈率比较无显著性差异，但总有效率比较有显著性差异（P〈0．05）；治疗前后甲状腺结节大小比较有显著性差异（P〈0．05）（多发结节以最大者计入）；各组治疗前后的FT3、FT4差异均无统计学意义，P〉0．05；治疗组的TSH在治疗前后差异无统计学意义，P〉0．05；对照组的TSH治疗后明显低于治疗前，P〈0．05。结论：肺脾同治自拟中药治疗甲状腺结节疗效、安全性优于单纯口服甲状腺激素治疗。     

中西医结合治疗眼眶骨折致眼眶瘀肿及眶下神经知觉障碍临床观察

目的 :观察早期运用中西医结合疗法治疗眼眶骨折致眼眶瘀肿及眶下神经知觉障碍的临床疗效。方法 :将76例(82眼)眶骨骨折患者按随机数字表法分为对照组和治疗组各38例(41眼)。对照组予抗生素、地塞米松静脉滴注,B族维生素及甲钴胺片口服,并对症治疗;治疗组在对照组的基础上辨证运用自拟经验方眼眶骨折1号方、眼眶骨折2号方。观察两组治疗后眼眶瘀肿及眶下神经知觉障碍改善情况,综合评价疗效。结果:治疗组软组织肿胀、眼睑瘀血、结膜下瘀血平均消退时间均短于对照组,差异有统计学意义(P<0.05)。眶下神经知觉障碍改善情况,治疗组显效6例,有效12例,无效0例,总有效率100%;对照组显效2例,有效12例,无效6例,总有效率70%;治疗组疗效明显优于对照组,差异有统计学意义(P<0.05)。结论:早期运用中西医结合疗法治疗眶骨骨折安全、有效,能加快眶周软组织损伤修复,缩短眼眶瘀肿消退时间,改善眶下神经知觉障碍。与单纯西医治疗比较,中西医结合疗法能缩短疗程、提高临床疗效。     

晚期癌症患者中医辨证分型分布及其同生存期的相关性分析研究

背景与目的：晚期癌症患者的中医辨证分型具有同西医症状评估不同的特点。通过对晚期癌症患者进行中医辨证分型的分类，研究其同西医症状及患者生存期之间的相关性。方法：通过MD Anderson症状评估量表（MD Anderson Symptom Inventory-Chinese，MDASI-C）收集临床患者症状分布及强度，并通过望闻问切判断患者的中医辨证分型。描述性分析用于人口统计学及临床特征资料的分析。对辨证分型为肝肾阴虚型（Ⅳ型）和其他型的患者进行t检验及χ²检验。应用Kaplan-Meier方法计算生存期，Log-rank进行显著性检验。结果：根据中医辨证分型，227例晚期癌症患者中，Ⅳ型共82例（36%）。Ⅳ型与其他5型相比，乏力和气急的发生频率和强度均较高。Ⅳ型患者同其他5型患者之间生存差异有统计学意义（P<0.05）。美国东部肿瘤协作组（Eastern Cooperative Oncology Group，ECOG）评分和Ⅳ型为晚期癌症患者生存期的预后因素。结论：本研究证实中医辨证分型对晚期癌症患者生存期有辨识作用，可提高晚期癌症生存期预测的准确性。在临床工作中，以此辅助检测病情变化，有助于临床医师更好地判断晚期癌症患者的生存预后。     

中西医结合治疗对原发性高血压患者血压及生存质量改善的临床观察

目的:观察中西医结合治疗对原发性高血压(肝肾阴虚证)患者血压及生存质量的改善情况。方法:采用随机、对照方法,将120例原发性高血压患者分为观察组和对照组各60例,对照组用硝苯地平缓释片治疗,观察组在对照组西药的基础上,加用中药汤剂治疗,疗程为3个月,观察治疗前后患者临床表现、血压水平及生存质量改善情况。结果:治疗后,观察组在中医证候疗效、血压水平、生存质量躯体健康、躯体角色功能、躯体疼痛、总体健康、活力、社会功能、心理健康方面均明显优于对照组,差异具有统计学意义(P<0.05),治疗后两组情绪角色功能方面差异无统计学意义(P>0.05)。结论:与单纯西药相比,中西医结合治疗原发性高血压在临床表现、血压水平、生存质量改善情况均有明显优势。     

中西医结合治疗口腔扁平苔藓的临床疗效观察

目的观察中西医结合治疗口腔扁平苔藓的临床效果。方法选取从2012年1月-2013年1月我院口腔科收治的40例口腔扁平苔藓患者，按就诊顺序随机分为对照组和治疗组各20例。对照组患者注射卡介菌多糖进行治疗，实验组患者在对照组基础上结合中药方剂进行治疗。结果治疗前，2组患者的疼痛评分比较，差异无统计学意义（t=0．151，P〉0．05）。采用不同方式治疗后，2组患者的疼痛评分比较，差异有统计学意义（t=9．631，P〈0．05）；对照组的总有效率为85．0％，实验组的总有效率为95．0％，实验组明显优于对照组，差异有统计学意义（P〈0．05）。结论采取中西医结合治疗口腔扁平苔藓，能使患者的疼痛情况得到缓解，有助于治疗效果的提升，具有临床应用及推广价值。     

中医外治法在高血压病治疗中的应用

高血压病是世界性常见病和多发病，是我国脑卒中和冠心病的主要致病因素，传统西医治疗有明显副作用，中医外治法在高血压病治疗护理方面效果良好，无毒副作用，价格低廉，患者易于接受，便于推广。     

Visual-perceptual-kinesthetic inputs on influencing writing performances in children with handwriting difficulties

This study investigated the role of visual-perceptual input in writing Chinese characters among senior school-aged children who had handwriting difficulties (CHD). The participants were 27 CHD (9–11 years old) and 61 normally developed control. There were three writing conditions: copying, and dictations with or without visual feedback. The motor-free subtests of the Developmental Test of Visual Perception (DTVP-2) were conducted. The CHD group showed significantly slower mean speeds of character production and less legibility of produced characters than the control group in all writing conditions (ps < 0.001). There were significant deteriorations in legibility from copying to dictation without visual feedback. Nevertheless, the Group by Condition interaction effect was not statistically significant. Only position in space of DTVP-2 was significantly correlated with the legibility among CHD (r = −0.62, p = 0.001). Poor legibility seems to be related to the less-intact spatial representation of the characters in working memory, which can be rectified by viewing the characters during writing. Visual feedback regarding one's own actions in writing can also improve legibility of characters among these children.     

重症肢体缺血的中西医治疗进展

慢性下肢动脉硬化闭塞症引起的重症下肢缺血是血管外科治疗的难题,临床治疗包括药物治疗、外科手术、腔内手术、腔内手术和介入手术结合的杂交手术、干细胞移植及中医中药治疗,以上各方面治疗均取得可喜的成绩,现综述如下。     

Potential advantages of a combination of Chinese Medicine and bone marrow mesenchymal stem cell transplantation for removing blood stasis and stimulating neogenesis during ischemic stroke treatment

Combined treatment of ischemic stroke with Chinese medicine and exogenous bone marrow mesenchymal stem cell(BMSC) transplantation may improve the removal of blood stasis and stimulation of neogenesis.Chinese medicines that remove blood stasis not only promote blood circulation but also calm the endopathic wind,remove heat,resolve phlegm,remove toxic substances and strengthen body resistance.The medicinal targeting effect of Chinese medicine can promote the homing of BMSCs,and the synergistic therapeutic effects of drugs can contribute to BMSC differentiation.As such,exogenous BMSC transplantation has potential advantages for neogenesis.Chinese medicines and exogenous BMSCs provide complementary functions for the removal of blood stasis and stimulation of neogenesis.Therefore,a combination of Chinese medicine and transplantation of exogenous BMSCs may be particularly suited to ischemic stroke treatment.     

How Picky Eating Becomes an Illness—Marketing Nutrient-Enriched Formula Milk in a Chinese Society

The essential adaptive food selection behavior of young children has become increasingly medicalized as a kind of disease—the “picky-eating” syndrome in Hong Kong. The researcher used the multiple case studies approach with data collected from in-depth interviews and advertisements to examine the process of the medicalization of picky-eating disorder, which demonstrates how an essential adaptive human behavior can be redefined by the market and medical system as a deviant, abnormal behavior that needs to be eliminated and how the resulting health risks can be resolved by modern medicine produced by this pharmaceutical nexus.